NASDAQ:CYT

Cyteir Therapeutics, Inc.

Stock

USD

Last Close

3.09

15/03 20:00

Market Cap

108.71M

Beta: -

Volume Today

1.01M

Avg: 56.88K

PE Ratio

−3.67

PFCF: −4.34

Overview Financials Filings people Ownership API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22
net income	-15.04M -	-20.82M 38.41%	-42.13M 102.31%	-46.06M 9.34%
depreciation and amortization	215K -	351K 63.26%	479K 36.47%	668K 39.46%
deferred income tax		-142K -	-4.42M 3,014.79%
stock based compensation	247K -	467K 89.07%	3.46M 641.97%	4.68M 35.12%
change in working capital	-2.16M -	1.47M 167.87%	2.15M 46.66%	-2.53M 217.58%
accounts receivables
inventory
accounts payables	-884K -	1.03M 216.18%	38K 96.30%	-657K 1,828.95%
other working capital	-1.28M -	439K 134.40%	2.11M 381.09%	-1.87M 188.59%
other non cash items	-815K -	142K 117.42%	4.42M 3,014.79%	707K 84.02%
net cash provided by operating activities	-17.56M -	-18.54M 5.59%	-36.03M 94.36%	-42.53M 18.04%
investments in property plant and equipment	-133K -	-850K 539.10%	-1.19M 39.88%	-312K 73.76%
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites	-133K -	-850K 539.10%	-1.19M 39.88%	-312K 73.76%
debt repayment
common stock issued	36.89M -	1.43M 96.13%	136.12M 9,438.89%	64K 99.95%
common stock repurchased
dividends paid
other financing activites			79.89M -	178K 99.78%
net cash used provided by financing activities	36.89M -	1.43M 96.13%	216.01M 15,037.07%	242K 99.89%
effect of forex changes on cash
net change in cash	19.20M -	-17.96M 193.55%	178.78M 1,095.35%	-42.60M 123.83%
cash at beginning of period	9.96M -	29.16M 192.85%	11.19M 61.61%	189.98M 1,597.15%
cash at end of period	29.16M -	11.19M 61.61%	189.98M 1,597.15%	147.38M 22.42%
operating cash flow	-17.56M -	-18.54M 5.59%	-36.03M 94.36%	-42.53M 18.04%
capital expenditure	-133K -	-850K 539.10%	-1.19M 39.88%	-312K 73.76%
free cash flow	-17.69M -	-19.39M 9.60%	-37.22M 91.97%	-42.84M 15.11%

All numbers in USD (except ratios and percentages)